Company / Operating Cash Flow per Share
Imunon, Inc. Operating Cash Flow per Share History
FY2015-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$0.27
FY2023
5-year range
-$5.76 / -$0.27
FY2019-FY2023
Trend
+90.5%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share has fluctuated over the past 7 years, ranging from $-5.76 in FY2021 to $-0.27 in FY2023.
Based on SEC 10-K filings.
-0.27 in FY2023.
Improved from $-5.76 to $-0.27 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2023, operating cash flow per share increased 90.5% year-over-year.
- Lowest operating cash flow per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.82 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | -$0.27 | +90.5% |
| FY2022 | -$2.81 | +51.2% |
| FY2021 | -$5.76 | -560.8% |
| FY2020 | -$0.87 | -133.0% |
| FY2019 | -$0.37 | +61.2% |
| FY2018 | -$0.96 | -102.1% |
| FY2015 | -$0.48 | - |
As of FY2023 · SEC 10-K · Updated Jun 24, 2026